Selecting Patients for Secondary Surgery in Ovarian Cancer
Author Information
Author(s): Onda T, Yoshikawa H, Yasugi T, Yamada M, Matsumoto K, Taketani Y
Primary Institution: Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo
Hypothesis
The study aims to clarify the ideal candidates for secondary cytoreductive surgery (SCS) in patients with recurrent ovarian cancer.
Conclusion
Patients with three or all four favorable factors at recurrence have significantly better survival outcomes after secondary cytoreductive surgery.
Supporting Evidence
- 59.1% of patients achieved complete removal of all visible tumors at secondary cytoreductive surgery.
- Patients with three or all four favorable factors had a median survival of 47 months compared to 20 months for others.
- Statistical analysis showed significant associations between favorable factors and overall survival.
Takeaway
Doctors can help women with recurring ovarian cancer live longer by choosing the right patients for a special surgery that removes tumors.
Methodology
The study involved univariate and multivariate analyses of variables before starting secondary cytoreductive surgery in 44 patients.
Potential Biases
The selection criteria may introduce bias as they are based on preoperative assessments.
Limitations
The study is retrospective and noncomparative, based on a relatively small number of strictly selected patients.
Participant Demographics
Patients had a median age of 52 years, with a range of 37 to 74 years, and included various stages of ovarian cancer.
Statistical Information
P-Value
0.0019
Confidence Interval
0.20–0.68
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website